It may also be suggested that decreased serum omentin-1 in IBS patients could be involved in the metabolic disorders observed in this group, as this adipokine has been proven to have a positive impact on insulin sensitivity and the concentrations of adiponectin and HDL [63,64,65]. The gene discussed is ADIPOQ; the disease is irritable bowel syndrome.